Mark Bachleda
Nessuna posizione attualmente
Patrimonio netto: 2 277 $ in data 30/04/2024
Provenienza dei contatti di primo grado di Mark Bachleda
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 4 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Mark Bachleda tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| IONIS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| ANTARES PHARMA, INC. | Pharmaceuticals: Major | Human Resources Officer | |
| Thomas Jefferson University | College/University | Corporate Officer/Principal | |
| AUXILIUM PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Human Resources Officer | |
| University of Virginia | College/University | Undergraduate Degree | |
King & Spalding LLP
 King & Spalding LLP Miscellaneous Commercial ServicesCommercial Services King & Spalding LLP provides legal services. The firm offers corporate, finance, investments, government matters, trial and global dispute capabilities services. The company was founded by Alexander King and Jack Spalding on January 1, 1885 and is headquartered in Atlanta, GA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| Princeton University | College/University | Undergraduate Degree | |
| State University of New York at Buffalo | College/University | Doctorate Degree | |
Ascenta Therapeutics, Inc.
 Ascenta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ascenta Therapeutics, Inc. engages in the discovery and development of medicines for cancer. Its core technology consists of agents designed to re-establish the natural program of apoptosis (cell death) in abnormal cancer cells. Its has three small molecule programs against distinct apoptosis targets: Bcl-2 (AT-101 – an oral pan-Bcl2 inhibitor), IAP (AT-406 – an oral multi-IAP inhibitor) and HDM2. The company was founded by Dajun Yang, Marc E. Lippman, and Shaomeng Wang on June 5, 2006 and is headquartered in Malvern, PA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
National Cancer Institute
 National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous National Cancer Institute provides healthcare services. It specializes in different cancer treatment such as adrenocortical carcinoma, anal cancer, appendix cancer, skin cancer, breast cancer, cardiac tumors, endometrial cancer, and gallbladder cancer. The company was founded in March 1937 and is headquartered in Bethesda, MD. | Investment Trusts/Mutual Funds | Corporate Officer/Principal | |
The Wistar Institute
 The Wistar Institute BiotechnologyHealth Technology The Wistar Institute provides biomedical research services. It researches on diseases such as cancer, cardiovascular, autoimmune disorders and infectious diseases and develops vaccine. The company was founded in 1892 and is headquartered in Philadelphia, PA | Biotechnology | General Counsel | |
Aspire IRB LLC
 Aspire IRB LLC Miscellaneous Commercial ServicesCommercial Services Aspire IRB LLC operates as an independent review board that provides human subject protection oversight in clinical trials for life science companies. The private company is based in San Diego, CA and has subsidiaries in the United States. | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer | |
| Medical College of Virginia | College/University | Doctorate Degree | |
| Aventis Behring LLC | Public Communications Contact | ||
FXI Holdings, Inc.
 FXI Holdings, Inc. Industrial SpecialtiesProcess Industries FXI Holdings, Inc. engages in the provision of foam solutions. It offers bedding, furniture, transportation, and tehcnical solutions. The firm serves the home, healthcare, electronics, industrial, personal care, and transportation industries. The company was founded in 2009 and is headquartered in Radnor, PA. | Industrial Specialties | General Counsel | |
The Hope Funds for Cancer Research
 The Hope Funds for Cancer Research Miscellaneous Commercial ServicesCommercial Services The Hope Funds for Cancer Research provides funds for cancer research. The private company is based in Newport, RI. The company was founded by Leah Rush Cann. | Miscellaneous Commercial Services | Director/Board Member | |
| University of California | College/University | Undergraduate Degree | |
| The University of Pennsylvania Law School | College/University | Graduate Degree | |
Termowood AS
 Termowood AS Forest ProductsNon-Energy Minerals Termowood AS develops and trades construction materials. Its products include wall isolation, wood panels, roofing, siding, and insulation material. The company was founded in 2012 and is headquartered in Drammen, Norway. | Forest Products | Chief Executive Officer | |
Context Therapeutics LLC
 Context Therapeutics LLC Pharmaceuticals: MajorHealth Technology Context Therapeutics LLC develops novel medicines for hormone responsive cancers. The company was founded by Martin Lehr in 2016 and is headquartered in Philadelphia, PA. | Pharmaceuticals: Major | Director/Board Member | |
| LUMOS PHARMA, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| CONTEXT THERAPEUTICS INC. | Pharmaceuticals: Major | Director/Board Member | |
| Innovative Cellular Therapeutics, Inc. | Chief Tech/Sci/R&D Officer | ||
| CARISMA THERAPEUTICS, INC. | Biotechnology | Chief Tech/Sci/R&D Officer |
Statistiche
Distribuzione geografica
| Stati Uniti | 26 |
| Norvegia | 2 |
Settori
| Health Technology | 12 |
| Consumer Services | 8 |
| Commercial Services | 4 |
| Miscellaneous | 2 |
| Process Industries | 2 |
Posizioni
| Chief Tech/Sci/R&D Officer | 8 |
| General Counsel | 6 |
| Corporate Secretary | 6 |
| Corporate Officer/Principal | 6 |
| Undergraduate Degree | 3 |
Contatti più connessi
| Insiders | |
|---|---|
| Jennifer Stacey | 12 |
| Eugene Kennedy | 9 |
| Jon T. Holmlund | 6 |
| Henning Thorsen | 3 |
- Borsa valori
- Insiders
- Mark Bachleda
- Connessioni Società